Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is it time to redefine the management of febrile neutropenia in cancer patients?

× No keyword cloud information.

5 in total

Review 1. Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer.

Authors: G Dranitsaris
Journal: Pharmacoeconomics Date: 1999-10 Impact factor: 4.981

2. Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.

Authors: Edwin Pun Hui; Linda K S Leung; Terence C W Poon; Frankie Mo; Vicky T C Chan; Ada T W Ma; Annette Poon; Eugenie K Hui; So-Shan Mak; Maria Lai; Kenny I K Lei; Brigette B Y Ma; Tony S K Mok; Winnie Yeo; Benny C Y Zee; Anthony T C Chan
Journal: Support Care Cancer Date: 2010-09-04 Impact factor: 3.603

Review 3. [Febrile neutropenia: practical aspects].

Authors: P Harten; B Seyfarth; N Schmitz
Journal: Med Klin (Munich) Date: 1998-10-15

4. Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy. For the treatment of febrile episodes in neutropenic patients.

Authors: J A Paladino; L D Fong; A Forrest; R Ramphal
Journal: Pharmacoeconomics Date: 2000-10 Impact factor: 4.981

5. Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients.

Authors: Letícia Carvalho Neuenschwander; Henrique Bittencourt; Ana Flávia Tibúrcio Ribeiro; Antônio Lúcio Teixeira; Mauro M Teixeira; Jairo Cerqueira Teixeira; Vandack Nobre
Journal: Clinics (Sao Paulo) Date: 2011 Impact factor: 2.365

5 in total